Evidence map›Paper›PMID 37511781›Full record

ReviewJournal of personalized medicine2023

Surgical Approaches to Pancoast Tumors.

Francesco Petrella, Monica Casiraghi, Luca Bertolaccini, Lorenzo Spaggiari

Open access · goldAbstract readReview
In one paragraph

Review in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Francesco PetrellaDivision of Thoracic Surgery, IRCCS European Institute of Oncology, 20141 Milan, Italy.ORCID 0000-0001-5945-1576
Monica CasiraghiDivision of Thoracic Surgery, IRCCS European Institute of Oncology, 20141 Milan, Italy.
Luca BertolacciniDivision of Thoracic Surgery, IRCCS European Institute of Oncology, 20141 Milan, Italy.ORCID 0000-0002-1153-3334
Lorenzo SpaggiariDivision of Thoracic Surgery, IRCCS European Institute of Oncology, 20141 Milan, Italy.
University of Milan · ITEuropean Institute of Oncology · IT

Funding

Italian Ministry of Health with "Ricerca Corrente", "5 × 1000" funds. 000000
6 · The paper itself

Abstract

Pancoast tumors, also defined as superior sulcus tumors, still represent a complex clinical condition requiring high technical surgical skills within more articulated multimodality treatment. The morbidity and mortality rates after Pancoast tumor treatments range from 10 to 55% and 0 to 7%, respectively, and the 5-year survival rate has significantly improved in recent years thanks to the advancement of treatments. Although a multimodality approach combining chemotherapy, radiotherapy, and surgery allows for radical resection and effective local control in the vast majority of patients, many patients cannot receive surgical resection or complete the whole programmed therapeutic regimen. Systemic relapse, particularly cerebral recurrence, still poses a significant issue in this cohort of patients. Surgical resection still plays a pivotal role within the multimodality approach. Here, we focus on surgical approaches to both anterior and posterior Pancoast tumors: the anterior transclavicular approach (Dartevelle); the anterior transmanubrial approach (Grunenwald-Spaggiari); the anterior trap-door approach (Masaoka, Nomori); the posterior approach (Shaw-Paulson); the hemiclamshell approach; and hybrid approaches. Global clinical condition, tumor histology, and long-term perspectives should always be taken into consideration when embarking on such a demanding oncologic scenario.

Indexed as

anterior approachchest wallnon-small-cell lung cancerPaulson approachtransclavicular approachtransmanubrial approach

Identifiers

PMID37511781
PMCPMC10381713
OpenAlexW4385219239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.